SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Kos Pharmaceuticals, Inc (KOSP)
An SI Board Since March 1997
Posts SubjectMarks Bans Symbol
118 20 0 KOSP
Emcee:  DD™ Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
93>>10:39AM KOS Pharma down on misinterpretation of FDA news -- Ryan Beck (Ktuck-5/13/2003
92>>Monday May 12, 2:21 pm ET POMONA, N.Y. (Dow Jones)--Barr Laboratories tuck-5/12/2003
91>>MIAMI, April 2 /PRNewswire-FirstCall/ -- At the Annual Scientific Sessiotuck-4/2/2003
90>>MIAMI, Feb. 4 /PRNewswire-FirstCall/ -- Kos Pharmaceuticals, Inc. (Nasdatuck-2/4/2003
89ijfrankel, Here is the link I tried to post on Yahoo. 216.239.33.100 bobrobert miller-2/2/2003
88My Mom was getting a rash that may or may not have been a reaction to Niaspan. tuck-1/27/2003
87Thanks, Robert, I'll check with my Mom and see why she's switching fromtuck-1/17/2003
86It is my understanding that Zetia's primary effect is additional lowering ofrobert miller-1/17/2003
85Peter, Vector, & Whoever is paying attention, A little anecdotal evidence otuck-1/11/2003
84>>CHICAGO, Nov. 20 /PRNewswire-FirstCall/ -- Kos Pharmaceuticals (Nasdaq: tuck-11/20/2002
83Nice Q for KOSP: >>MIAMI, Nov. 7 /PRNewswire-FirstCall/ -- Kos Pharmaceuttuck-11/7/2002
82>>DARMSTADT, Germany, and MIAMI, Oct. 24 /PRNewswire-FirstCall/ -- Merck Ktuck-10/24/2002
81I actually ended up trading KOSP a couple of times. Not that liquid but it kepttuck-10/9/2002
80Kos Pharmaceuticals Files SNDA For Niaspan DOW JONES NEWSWIRES MIAMI -- Kos Phmopgcw-10/7/2002
79Tuck, I agree. I think the Jaharis clan are true believers. Can't fault themVector1-9/25/2002
78Right. I was wondering if the old "buy the convert short the common play&qutuck-9/24/2002
77Tuck, this is a highly leveraged play. Because of the convert if niaspan and AdvVector1-9/24/2002
76V1 & Peter, Thanks for your comments on the patent issue. Have been watchituck-9/24/2002
75Does anyone know if BRL must now file a paragraph 4 certification of the invalidIRWIN JAMES FRANKEL-8/26/2002
74Hi guys, The new patent is interesting, link: patft.uspto.gov I thought this IRWIN JAMES FRANKEL-8/21/2002
73Biomaven, I agree that this patent sounds like it might be important. Usually thVector1-8/21/2002
72Tuck, Yes, I believe this is significant. The method-of-use patents were alwaysBiomaven-8/21/2002
71Peter, KOSP adds a small arrow to its patent quiver; do you think this improvestuck-8/21/2002
70Briefing: <i>07:46 ET KOSP KOS Pharma submits SNDA for expanded Niaspatom pope-7/22/2002
69Sure, you are completely right. I do hold both. A bad excuse but still an excuseIcebrg-5/15/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News